VerifiedEvidence: highv1.0.0

Equity-Weighted Analysis

An economic evaluation that applies differential weights to health gains in different population groups, giving greater weight to gains for disadvantaged groups.

Last reviewedDarrin Baines IP Ltd

Concept Architecture

Concept


Theoretically, Equity-Weighted Analysis is an extension of economic evaluation that adjusts health outcomes or net benefits according to explicit social value judgements regarding equity. The approach is grounded in welfare economics and social choice theory, recognising that society may place greater value on health gains achieved in disadvantaged, severely ill or underserved populations than on equivalent gains achieved elsewhere. Equity-weighted analysis therefore modifies conventional efficiency-based evaluations by incorporating distributional preferences into decision-making.

Mathematically, equity-weighted analysis applies weighting factors to health outcomes or net benefits before aggregation. The weights represent societal preferences regarding the distribution of health gains and may vary according to characteristics such as disease severity, socioeconomic status, age or lifetime health. These weights are incorporated into decision models to produce equity-adjusted estimates of effectiveness, net benefit or social welfare. The weighting scheme is defined externally through empirical preference elicitation or policy guidance rather than derived from the evaluation itself.

In practice, equity-weighted analysis is implemented within cost-effectiveness or cost-utility analyses by assigning predefined equity weights to individual or population-level health gains. The weighted outcomes are then combined with cost estimates to inform reimbursement and resource allocation decisions that explicitly consider both efficiency and equity. The approach is increasingly applied in health technology assessment where decision-makers seek to balance maximising total health with reducing health inequalities.


Purpose


Used to incorporate societal preferences for fairness into economic evaluation by assigning greater or lesser value to health gains achieved in different population groups, thereby supporting equity-informed healthcare resource allocation.


Mathematical Formulae

Primary Formula

Equity-Weighted Health Benefit = ?(w? ? E?)

where:

  • w? = equity weight assigned to population group i
  • E? = health benefit for population group i

Supporting Formulae

Equity-Weighted Net Monetary Benefit:

NMB? = ? ? ?(w? ? E?) ? C

Weighted QALYs:

Weighted QALYs = ?(w? ? QALY?)

Related Mathematical Methods

  • Distributional Cost-Effectiveness Analysis
  • Cost-Effectiveness Analysis
  • Cost-Utility Analysis
  • Net Monetary Benefit
  • Social Welfare Function
  • Equity Impact Analysis

Example


A programme generates 100 QALYs in a disadvantaged population. Policy guidance assigns an equity weight of 1.4 to health gains in this group.

Equity-Weighted QALYs = 1.4 ? 100 = 140 weighted QALYs

If the intervention costs �2,800,000, the equity-adjusted cost-effectiveness assessment is based on 140 weighted QALYs rather than the unweighted 100 QALYs.


Excel Implementation

FunctionExample FormulaHealth Economics Application
SUMPRODUCT=SUMPRODUCT(WeightRange,QALYRange)Calculates equity-weighted health outcomes across population groups.
XLOOKUP=XLOOKUP(Group,GroupList,WeightList)Retrieves predefined equity weights.
LET=LET(W,B2,E,C2,W*E)Calculates weighted health benefit for an individual group.
SUM=SUM(WeightedBenefitRange)Aggregates weighted health outcomes across all groups.
IF=IF(Group="High Priority",QALY*1.4,QALY)Applies policy-defined equity weights to selected populations.

VBA (Optional)


VBA can automate equity-weighted cost-effectiveness analyses by applying policy-defined weighting schemes across multiple patient groups and producing equity-adjusted summary results.


Sources

  • Cookson R, Griffin S, Norheim OF, Culyer AJ. Distributional Cost-Effectiveness Analysis: Quantifying Health Equity Impacts and Trade-Offs. Oxford University Press.
  • Asaria M, Griffin S, Cookson R. Distributional Cost-Effectiveness Analysis: A Tutorial. Medical Decision Making.
  • NICE. Health Technology Evaluation Manual.
  • Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press.
  • Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford University Press.

Institutional Perspectives (2)

  • NICE

    DCEA Explored but Not a Reference-Case Requirement

    Health-inequality impacts are not formally or quantitatively incorporated into standard appraisal decisions; the reference case weights each QALY equally (aside from the severity modifier). NICE has begun applying Distributional Cost-Effectiveness Analysis in selected appraisals to describe how health effects fall across social groups, but DCEA is an emerging method rather than a mandatory reference-case analysis, and equity dimensions are mainly handled through deliberation.

    NICE Health Technology Evaluations: The Manual (PMG36); NICE applications of Distributional Cost-Effectiveness AnalysisView source
  • ICER

    Equity Considered via a Health-Equity Framework, Not Formal Weighting

    ICER embeds equity across its assessment lifecycle through a health-equity framework and qualitative/contextual considerations rather than formal equity weights. It has concluded that quantitative methods such as equity weighting, extended cost-effectiveness analysis, and distributional cost-effectiveness analysis need further work on data and interpretation before routine use.

    Institute for Clinical and Economic Review, Health Equity framework / Value Assessment FrameworkView source

Library

Publications

1
  • Book

    Distributional Cost-Effectiveness Analysis: Quantifying Health Equity Impacts and Trade-Offs — Cookson, Griffin, Norheim & Culyer, 1st Edition ed., 2020 (Oxford University Press)

    The definitive practical guide to distributional cost-effectiveness analysis (DCEA), a suite of methods for quantifying who gains and who loses from health programmes and the trade-offs between improving total health and reducing unfair health inequality. Volume 7 in the Handbooks in Health Economic Evaluation series.

Media

1
  • Media

    Amartya Sen — Portrait (Wikimedia Commons) — Wikimedia Commons contributors, Openly licensed (see file page) ed., 2012 (Wikimedia Commons)

    Openly-licensed portraits of Amartya Sen, Nobel laureate whose capability approach and work on welfare, equity and social choice underpin distributional and equity analysis in health economics. Each image on the category page carries its own open licence.

Frequently Asked Questions (6)

  • What is equity-weighted analysis?

    An economic evaluation that applies differential weights to health gains in different population groups, giving greater weight to gains for disadvantaged groups.

    Source: Cookson et al. 2021

  • How does equity-weighted analysis work?

    Health gains are multiplied by weights that differ according to who receives them, so a quality-adjusted life year accruing to a disadvantaged group counts for more than one accruing to an advantaged group. The weighted totals are then compared across options in the usual way. The weights make explicit a judgement that conventional analysis makes implicitly, since treating every unit of health as equal is itself a distributive position rather than a neutral one. The approach therefore does not introduce a value judgement into an otherwise neutral calculation; it replaces one distributive assumption with another and states it.

    Source: Cookson et al. 2021

  • Where do the weights in an equity-weighted analysis come from?

    There is no agreed source, which is the central difficulty. Weights can be derived from surveys asking the public how much aggregate health they would sacrifice for a more equal distribution, from the implied weights in past decisions, or specified by the decision maker as a policy parameter. Because none of these produces a settled figure, analyses normally report results across a range of weights rather than adopting one, so the reader can see at what point the conclusion changes. Presenting the threshold weight at which the preferred option changes is frequently more useful than presenting a result at any single weight.

    Source: Cookson et al. 2021

  • How does equity-weighted analysis differ from distributional analysis?

    Distributional analysis reports how gains and losses fall across groups and leaves the weighing to the decision maker. Equity weighting applies the weights within the analysis and returns a single adjusted result. The first preserves transparency and requires judgement afterwards; the second embeds the judgement and produces a comparable figure. They are frequently used together, with the distribution reported and the weighted result shown as a scenario. In practice the two are complementary, and reporting the underlying distribution alongside any weighted figure preserves the information that weighting compresses. Both approaches depend on the same underlying subgroup evidence, so neither is available where effects have not been estimated by group.

    Source: Cookson et al. 2021

  • What does equity-weighted analysis require of the evidence?

    It requires effects to be estimated separately by group, including differences in baseline risk, uptake, adherence and the treatment effect itself, which trials rarely report by socioeconomic position. It also requires an assumption about where the displaced spending would have fallen, since the health forgone is distributed as well as the health gained. Both are frequently assumed rather than observed, and the assumptions can drive the equity conclusion more than the evidence does. Where subgroup effects are assumed rather than measured, the analysis should say so plainly, since a weighted result built on assumed differences is a scenario rather than an estimate.

    Source: Drummond et al. 2015

  • What objections are raised to equity-weighted analysis?

    That the weights are arbitrary in the absence of an agreed basis, so the analysis can produce whichever answer the chosen weight implies. That weighting by group membership treats individuals as representatives of categories. That it addresses one dimension of disadvantage while others go unweighted. And that combining efficiency and equity into a single number removes the trade-off from view, which is the opposite of what an explicit treatment of equity was meant to achieve. Reporting results across a range of weights rather than adopting one answers most of these objections, at the cost of not producing the single figure that made the approach attractive.

    Source: Neumann, Sanders et al. 2016

Trust Record

Verified by Dr Darrin Baines

British health economist

Professional identity: darrinbaines.org

Verification date: 6 Aug 2025

Content version: 1.0.0

Canonical Identity

Term code
HE-EE-CEA-026

Stable URI · Machine-readable · Resolvable · CC BY 4.0